161 related articles for article (PubMed ID: 23150173)
1. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
Ishii T; Kira N; Yoshida T; Narahara H
Tumour Biol; 2013 Feb; 34(1):285-91. PubMed ID: 23150173
[TBL] [Abstract][Full Text] [Related]
2. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
[TBL] [Abstract][Full Text] [Related]
3. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Gynecol Oncol; 2008 Apr; 109(1):107-14. PubMed ID: 18234298
[TBL] [Abstract][Full Text] [Related]
4. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
[TBL] [Abstract][Full Text] [Related]
5. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
[TBL] [Abstract][Full Text] [Related]
6. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nasu K; Narahara H
Gynecol Oncol; 2008 Nov; 111(2):336-43. PubMed ID: 18790523
[TBL] [Abstract][Full Text] [Related]
7. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
[TBL] [Abstract][Full Text] [Related]
8. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
Ueda T; Takai N; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
[TBL] [Abstract][Full Text] [Related]
9. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
Takai N; Narahara H
Curr Med Chem; 2007; 14(24):2548-53. PubMed ID: 17979707
[TBL] [Abstract][Full Text] [Related]
10. PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2010 Jan; 25(1):97-103. PubMed ID: 19956907
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Anticancer Res; 2006; 26(2A):939-45. PubMed ID: 16619490
[TBL] [Abstract][Full Text] [Related]
12. Cleistopholine isolated from Enicosanthellum pulchrum exhibits apoptogenic properties in human ovarian cancer cells.
Nordin N; Majid NA; Mohan S; Dehghan F; Karimian H; Rahman MA; Ali HM; Hashim NM
Phytomedicine; 2016 Apr; 23(4):406-16. PubMed ID: 27002411
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of cucurbitacin-A in ovarian cancer cell line SKOV3 involves cell cycle arrest, apoptosis and inhibition of mTOR/PI3K/Akt signaling pathway.
Liu J; Liu X; Ma W; Kou W; Li C; Zhao J
J BUON; 2018; 23(1):124-128. PubMed ID: 29552771
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.
Premkumar DR; Jane EP; Pollack IF
Cancer Biol Ther; 2015; 16(2):233-43. PubMed ID: 25482928
[TBL] [Abstract][Full Text] [Related]
15. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
Takai N; Ueda T; Kawano Y; Nishida M; Nasu K; Narahara H
Oncol Rep; 2005 Nov; 14(5):1287-91. PubMed ID: 16211298
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
17. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Oncol Rep; 2008 Mar; 19(3):749-53. PubMed ID: 18288411
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.
Duangmano S; Sae-Lim P; Suksamrarn A; Domann FE; Patmasiriwat P
BMC Complement Altern Med; 2012 Oct; 12():185. PubMed ID: 23062075
[TBL] [Abstract][Full Text] [Related]
19. The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2alpha in leukemia cells.
Li Y; Wang R; Ma E; Deng Y; Wang X; Xiao J; Jing Y
Anticancer Drugs; 2010 Apr; 21(4):389-400. PubMed ID: 20110807
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer.
Kim HJ; Park JH; Kim JK
Chem Biol Interact; 2014 Aug; 219():1-8. PubMed ID: 24858077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]